Illimis Therapeutics logo

Illimis Therapeutics jobs and careers

As of October 24, 2026, Illimis Therapeutics has no open roles listed.

About Illimis Therapeutics

Illimis Therapeutics is a platform-based Korean biotech company developing a chimeric fusion protein platform for neurodegenerative diseases such as Alzheimer’s. Our platform is differentiated by its ability to address the concerns of antibody-induced neuroinflammation and subsequent ARIA (Amyloid-Related Imaging Abnormalities) often observed from existing antibody drugs that utilize FcR-mediated phagocytosis of microglia, by utilizing TAM receptor, a novel phagocytic receptor expressed on the surface of glial cells.

Founded
2021
Employees
11 to 50

Leadership

The top of Illimis Therapeutics's org chart, with how many people report into each leader.

SPPhoto of Sanghoon Park

Sanghoon Park

Co-founder & CEO

Jobs at Illimis Therapeutics

No open positions right now. Explore more companies on TheJobsMap.

Illimis Therapeutics jobs: common questions

Is Illimis Therapeutics hiring right now?
Illimis Therapeutics has no open roles listed as of October 24, 2026. Roles appear here as soon as they are posted on Illimis Therapeutics's careers site.
Who leads Illimis Therapeutics?
Sanghoon Park, Co-founder & CEO, is at the top of Illimis Therapeutics's org chart.
How do I apply for a job at Illimis Therapeutics?
Pick a role on Illimis Therapeutics's TheJobsMap page and select Apply. Every listing links to the original posting on Illimis Therapeutics's own careers site, so you apply directly with the employer.